<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8"/>
<style>body{background-color:white;}</style>


</head>
<body>
<div id="cfwrtwgxqc" style="padding-left:0px;padding-right:0px;padding-top:10px;padding-bottom:10px;overflow-x:auto;overflow-y:auto;width:auto;height:auto;">
  <style>#cfwrtwgxqc table {
  font-family: system-ui, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
}

#cfwrtwgxqc thead, #cfwrtwgxqc tbody, #cfwrtwgxqc tfoot, #cfwrtwgxqc tr, #cfwrtwgxqc td, #cfwrtwgxqc th {
  border-style: none;
}

#cfwrtwgxqc p {
  margin: 0;
  padding: 0;
}

#cfwrtwgxqc .gt_table {
  display: table;
  border-collapse: collapse;
  line-height: normal;
  margin-left: auto;
  margin-right: auto;
  color: #333333;
  font-size: 12px;
  font-weight: normal;
  font-style: normal;
  background-color: #FFFFFF;
  width: auto;
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #A8A8A8;
  border-right-style: none;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #A8A8A8;
  border-left-style: none;
  border-left-width: 2px;
  border-left-color: #D3D3D3;
}

#cfwrtwgxqc .gt_caption {
  padding-top: 4px;
  padding-bottom: 4px;
}

#cfwrtwgxqc .gt_title {
  color: #333333;
  font-size: 125%;
  font-weight: initial;
  padding-top: 4px;
  padding-bottom: 4px;
  padding-left: 5px;
  padding-right: 5px;
  border-bottom-color: #FFFFFF;
  border-bottom-width: 0;
}

#cfwrtwgxqc .gt_subtitle {
  color: #333333;
  font-size: 85%;
  font-weight: initial;
  padding-top: 3px;
  padding-bottom: 5px;
  padding-left: 5px;
  padding-right: 5px;
  border-top-color: #FFFFFF;
  border-top-width: 0;
}

#cfwrtwgxqc .gt_heading {
  background-color: #FFFFFF;
  text-align: center;
  border-bottom-color: #FFFFFF;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
}

#cfwrtwgxqc .gt_bottom_border {
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
}

#cfwrtwgxqc .gt_col_headings {
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
}

#cfwrtwgxqc .gt_col_heading {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: normal;
  text-transform: inherit;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
  vertical-align: bottom;
  padding-top: 5px;
  padding-bottom: 6px;
  padding-left: 5px;
  padding-right: 5px;
  overflow-x: hidden;
}

#cfwrtwgxqc .gt_column_spanner_outer {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: normal;
  text-transform: inherit;
  padding-top: 0;
  padding-bottom: 0;
  padding-left: 4px;
  padding-right: 4px;
}

#cfwrtwgxqc .gt_column_spanner_outer:first-child {
  padding-left: 0;
}

#cfwrtwgxqc .gt_column_spanner_outer:last-child {
  padding-right: 0;
}

#cfwrtwgxqc .gt_column_spanner {
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  vertical-align: bottom;
  padding-top: 5px;
  padding-bottom: 5px;
  overflow-x: hidden;
  display: inline-block;
  width: 100%;
}

#cfwrtwgxqc .gt_spanner_row {
  border-bottom-style: hidden;
}

#cfwrtwgxqc .gt_group_heading {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  text-transform: inherit;
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
  vertical-align: middle;
  text-align: left;
}

#cfwrtwgxqc .gt_empty_group_heading {
  padding: 0.5px;
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  vertical-align: middle;
}

#cfwrtwgxqc .gt_from_md > :first-child {
  margin-top: 0;
}

#cfwrtwgxqc .gt_from_md > :last-child {
  margin-bottom: 0;
}

#cfwrtwgxqc .gt_row {
  padding-top: 3px;
  padding-bottom: 3px;
  padding-left: 5px;
  padding-right: 5px;
  margin: 10px;
  border-top-style: solid;
  border-top-width: 1px;
  border-top-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
  vertical-align: middle;
  overflow-x: hidden;
}

#cfwrtwgxqc .gt_stub {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  text-transform: inherit;
  border-right-style: solid;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
  padding-left: 5px;
  padding-right: 5px;
}

#cfwrtwgxqc .gt_stub_row_group {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  text-transform: inherit;
  border-right-style: solid;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
  padding-left: 5px;
  padding-right: 5px;
  vertical-align: top;
}

#cfwrtwgxqc .gt_row_group_first td {
  border-top-width: 2px;
}

#cfwrtwgxqc .gt_row_group_first th {
  border-top-width: 2px;
}

#cfwrtwgxqc .gt_summary_row {
  color: #333333;
  background-color: #FFFFFF;
  text-transform: inherit;
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
}

#cfwrtwgxqc .gt_first_summary_row {
  border-top-style: solid;
  border-top-color: #D3D3D3;
}

#cfwrtwgxqc .gt_first_summary_row.thick {
  border-top-width: 2px;
}

#cfwrtwgxqc .gt_last_summary_row {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
}

#cfwrtwgxqc .gt_grand_summary_row {
  color: #333333;
  background-color: #FFFFFF;
  text-transform: inherit;
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
}

#cfwrtwgxqc .gt_first_grand_summary_row {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  border-top-style: double;
  border-top-width: 6px;
  border-top-color: #D3D3D3;
}

#cfwrtwgxqc .gt_last_grand_summary_row_top {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  border-bottom-style: double;
  border-bottom-width: 6px;
  border-bottom-color: #D3D3D3;
}

#cfwrtwgxqc .gt_striped {
  background-color: rgba(128, 128, 128, 0.05);
}

#cfwrtwgxqc .gt_table_body {
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
}

#cfwrtwgxqc .gt_footnotes {
  color: #333333;
  background-color: #FFFFFF;
  border-bottom-style: none;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 2px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
}

#cfwrtwgxqc .gt_footnote {
  margin: 0px;
  font-size: 90%;
  padding-top: 4px;
  padding-bottom: 4px;
  padding-left: 5px;
  padding-right: 5px;
}

#cfwrtwgxqc .gt_sourcenotes {
  color: #333333;
  background-color: #FFFFFF;
  border-bottom-style: none;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 2px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
}

#cfwrtwgxqc .gt_sourcenote {
  font-size: 90%;
  padding-top: 4px;
  padding-bottom: 4px;
  padding-left: 5px;
  padding-right: 5px;
}

#cfwrtwgxqc .gt_left {
  text-align: left;
}

#cfwrtwgxqc .gt_center {
  text-align: center;
}

#cfwrtwgxqc .gt_right {
  text-align: right;
  font-variant-numeric: tabular-nums;
}

#cfwrtwgxqc .gt_font_normal {
  font-weight: normal;
}

#cfwrtwgxqc .gt_font_bold {
  font-weight: bold;
}

#cfwrtwgxqc .gt_font_italic {
  font-style: italic;
}

#cfwrtwgxqc .gt_super {
  font-size: 65%;
}

#cfwrtwgxqc .gt_footnote_marks {
  font-size: 75%;
  vertical-align: 0.4em;
  position: initial;
}

#cfwrtwgxqc .gt_asterisk {
  font-size: 100%;
  vertical-align: 0;
}

#cfwrtwgxqc .gt_indent_1 {
  text-indent: 5px;
}

#cfwrtwgxqc .gt_indent_2 {
  text-indent: 10px;
}

#cfwrtwgxqc .gt_indent_3 {
  text-indent: 15px;
}

#cfwrtwgxqc .gt_indent_4 {
  text-indent: 20px;
}

#cfwrtwgxqc .gt_indent_5 {
  text-indent: 25px;
}

#cfwrtwgxqc .katex-display {
  display: inline-flex !important;
  margin-bottom: 0.75em !important;
}

#cfwrtwgxqc div.Reactable > div.rt-table > div.rt-thead > div.rt-tr.rt-tr-group-header > div.rt-th-group:after {
  height: 0px !important;
}
</style>
  <table class="gt_table" data-quarto-disable-processing="false" data-quarto-bootstrap="false">
  <thead>
    <tr class="gt_heading">
      <td colspan="6" class="gt_heading gt_title gt_font_normal" style><span class='gt_from_md'><strong>Treatment-Emergent Adverse Events by Preferred Term</strong></span></td>
    </tr>
    <tr class="gt_heading">
      <td colspan="6" class="gt_heading gt_subtitle gt_font_normal gt_bottom_border" style>Cell values are unique subjects with TEAE: n (%) | Denominator = ADSL subjects by ACTARM | Total N = 306</td>
    </tr>
    <tr class="gt_col_headings">
      <th class="gt_col_heading gt_columns_bottom_border gt_left" rowspan="1" colspan="1" scope="col" id="a::stub"></th>
      <th class="gt_col_heading gt_columns_bottom_border gt_left" rowspan="1" colspan="1" scope="col" id="Total"><span class='gt_from_md'><strong>Total</strong><br>N=306</span></th>
      <th class="gt_col_heading gt_columns_bottom_border gt_left" rowspan="1" colspan="1" scope="col" id="Placebo"><span class='gt_from_md'><strong>Placebo</strong><br>N=86</span></th>
      <th class="gt_col_heading gt_columns_bottom_border gt_left" rowspan="1" colspan="1" scope="col" id="Screen-Failure"><span class='gt_from_md'><strong>Screen Failure</strong><br>N=52</span></th>
      <th class="gt_col_heading gt_columns_bottom_border gt_left" rowspan="1" colspan="1" scope="col" id="Xanomeline-High-Dose"><span class='gt_from_md'><strong>Xanomeline High Dose</strong><br>N=72</span></th>
      <th class="gt_col_heading gt_columns_bottom_border gt_left" rowspan="1" colspan="1" scope="col" id="Xanomeline-Low-Dose"><span class='gt_from_md'><strong>Xanomeline Low Dose</strong><br>N=96</span></th>
    </tr>
  </thead>
  <tbody class="gt_table_body">
    <tr><th id="stub_1_1" scope="row" class="gt_row gt_left gt_stub">PRURITUS</th>
<td headers="stub_1_1 Total" class="gt_row gt_left">54 (100.0%)</td>
<td headers="stub_1_1 Placebo" class="gt_row gt_left">8 (9.3%)</td>
<td headers="stub_1_1 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_1 Xanomeline High Dose" class="gt_row gt_left">25 (34.7%)</td>
<td headers="stub_1_1 Xanomeline Low Dose" class="gt_row gt_left">21 (21.9%)</td></tr>
    <tr><th id="stub_1_2" scope="row" class="gt_row gt_left gt_stub">APPLICATION SITE PRURITUS</th>
<td headers="stub_1_2 Total" class="gt_row gt_left">50 (100.0%)</td>
<td headers="stub_1_2 Placebo" class="gt_row gt_left">6 (7.0%)</td>
<td headers="stub_1_2 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_2 Xanomeline High Dose" class="gt_row gt_left">21 (29.2%)</td>
<td headers="stub_1_2 Xanomeline Low Dose" class="gt_row gt_left">23 (24.0%)</td></tr>
    <tr><th id="stub_1_3" scope="row" class="gt_row gt_left gt_stub">ERYTHEMA</th>
<td headers="stub_1_3 Total" class="gt_row gt_left">36 (100.0%)</td>
<td headers="stub_1_3 Placebo" class="gt_row gt_left">8 (9.3%)</td>
<td headers="stub_1_3 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_3 Xanomeline High Dose" class="gt_row gt_left">14 (19.4%)</td>
<td headers="stub_1_3 Xanomeline Low Dose" class="gt_row gt_left">14 (14.6%)</td></tr>
    <tr><th id="stub_1_4" scope="row" class="gt_row gt_left gt_stub">APPLICATION SITE ERYTHEMA</th>
<td headers="stub_1_4 Total" class="gt_row gt_left">30 (100.0%)</td>
<td headers="stub_1_4 Placebo" class="gt_row gt_left">3 (3.5%)</td>
<td headers="stub_1_4 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_4 Xanomeline High Dose" class="gt_row gt_left">14 (19.4%)</td>
<td headers="stub_1_4 Xanomeline Low Dose" class="gt_row gt_left">13 (13.5%)</td></tr>
    <tr><th id="stub_1_5" scope="row" class="gt_row gt_left gt_stub">RASH</th>
<td headers="stub_1_5 Total" class="gt_row gt_left">26 (100.0%)</td>
<td headers="stub_1_5 Placebo" class="gt_row gt_left">5 (5.8%)</td>
<td headers="stub_1_5 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_5 Xanomeline High Dose" class="gt_row gt_left">8 (11.1%)</td>
<td headers="stub_1_5 Xanomeline Low Dose" class="gt_row gt_left">13 (13.5%)</td></tr>
    <tr><th id="stub_1_6" scope="row" class="gt_row gt_left gt_stub">APPLICATION SITE DERMATITIS</th>
<td headers="stub_1_6 Total" class="gt_row gt_left">21 (100.0%)</td>
<td headers="stub_1_6 Placebo" class="gt_row gt_left">5 (5.8%)</td>
<td headers="stub_1_6 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_6 Xanomeline High Dose" class="gt_row gt_left">7 (9.7%)</td>
<td headers="stub_1_6 Xanomeline Low Dose" class="gt_row gt_left">9 (9.4%)</td></tr>
    <tr><th id="stub_1_7" scope="row" class="gt_row gt_left gt_stub">APPLICATION SITE IRRITATION</th>
<td headers="stub_1_7 Total" class="gt_row gt_left">21 (100.0%)</td>
<td headers="stub_1_7 Placebo" class="gt_row gt_left">3 (3.5%)</td>
<td headers="stub_1_7 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_7 Xanomeline High Dose" class="gt_row gt_left">9 (12.5%)</td>
<td headers="stub_1_7 Xanomeline Low Dose" class="gt_row gt_left">9 (9.4%)</td></tr>
    <tr><th id="stub_1_8" scope="row" class="gt_row gt_left gt_stub">DIZZINESS</th>
<td headers="stub_1_8 Total" class="gt_row gt_left">21 (100.0%)</td>
<td headers="stub_1_8 Placebo" class="gt_row gt_left">2 (2.3%)</td>
<td headers="stub_1_8 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_8 Xanomeline High Dose" class="gt_row gt_left">10 (13.9%)</td>
<td headers="stub_1_8 Xanomeline Low Dose" class="gt_row gt_left">9 (9.4%)</td></tr>
    <tr><th id="stub_1_9" scope="row" class="gt_row gt_left gt_stub">DIARRHOEA</th>
<td headers="stub_1_9 Total" class="gt_row gt_left">17 (100.0%)</td>
<td headers="stub_1_9 Placebo" class="gt_row gt_left">9 (10.5%)</td>
<td headers="stub_1_9 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_9 Xanomeline High Dose" class="gt_row gt_left">3 (4.2%)</td>
<td headers="stub_1_9 Xanomeline Low Dose" class="gt_row gt_left">5 (5.2%)</td></tr>
    <tr><th id="stub_1_10" scope="row" class="gt_row gt_left gt_stub">SINUS BRADYCARDIA</th>
<td headers="stub_1_10 Total" class="gt_row gt_left">17 (100.0%)</td>
<td headers="stub_1_10 Placebo" class="gt_row gt_left">2 (2.3%)</td>
<td headers="stub_1_10 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_10 Xanomeline High Dose" class="gt_row gt_left">8 (11.1%)</td>
<td headers="stub_1_10 Xanomeline Low Dose" class="gt_row gt_left">7 (7.3%)</td></tr>
    <tr><th id="stub_1_11" scope="row" class="gt_row gt_left gt_stub">HYPERHIDROSIS</th>
<td headers="stub_1_11 Total" class="gt_row gt_left">14 (100.0%)</td>
<td headers="stub_1_11 Placebo" class="gt_row gt_left">2 (2.3%)</td>
<td headers="stub_1_11 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_11 Xanomeline High Dose" class="gt_row gt_left">8 (11.1%)</td>
<td headers="stub_1_11 Xanomeline Low Dose" class="gt_row gt_left">4 (4.2%)</td></tr>
    <tr><th id="stub_1_12" scope="row" class="gt_row gt_left gt_stub">SKIN IRRITATION</th>
<td headers="stub_1_12 Total" class="gt_row gt_left">14 (100.0%)</td>
<td headers="stub_1_12 Placebo" class="gt_row gt_left">3 (3.5%)</td>
<td headers="stub_1_12 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_12 Xanomeline High Dose" class="gt_row gt_left">5 (6.9%)</td>
<td headers="stub_1_12 Xanomeline Low Dose" class="gt_row gt_left">6 (6.2%)</td></tr>
    <tr><th id="stub_1_13" scope="row" class="gt_row gt_left gt_stub">VOMITING</th>
<td headers="stub_1_13 Total" class="gt_row gt_left">13 (100.0%)</td>
<td headers="stub_1_13 Placebo" class="gt_row gt_left">3 (3.5%)</td>
<td headers="stub_1_13 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_13 Xanomeline High Dose" class="gt_row gt_left">6 (8.3%)</td>
<td headers="stub_1_13 Xanomeline Low Dose" class="gt_row gt_left">4 (4.2%)</td></tr>
    <tr><th id="stub_1_14" scope="row" class="gt_row gt_left gt_stub">NASOPHARYNGITIS</th>
<td headers="stub_1_14 Total" class="gt_row gt_left">12 (100.0%)</td>
<td headers="stub_1_14 Placebo" class="gt_row gt_left">2 (2.3%)</td>
<td headers="stub_1_14 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_14 Xanomeline High Dose" class="gt_row gt_left">6 (8.3%)</td>
<td headers="stub_1_14 Xanomeline Low Dose" class="gt_row gt_left">4 (4.2%)</td></tr>
    <tr><th id="stub_1_15" scope="row" class="gt_row gt_left gt_stub">NAUSEA</th>
<td headers="stub_1_15 Total" class="gt_row gt_left">12 (100.0%)</td>
<td headers="stub_1_15 Placebo" class="gt_row gt_left">3 (3.5%)</td>
<td headers="stub_1_15 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_15 Xanomeline High Dose" class="gt_row gt_left">6 (8.3%)</td>
<td headers="stub_1_15 Xanomeline Low Dose" class="gt_row gt_left">3 (3.1%)</td></tr>
    <tr><th id="stub_1_16" scope="row" class="gt_row gt_left gt_stub">APPLICATION SITE VESICLES</th>
<td headers="stub_1_16 Total" class="gt_row gt_left">11 (100.0%)</td>
<td headers="stub_1_16 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_16 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_16 Xanomeline High Dose" class="gt_row gt_left">5 (6.9%)</td>
<td headers="stub_1_16 Xanomeline Low Dose" class="gt_row gt_left">5 (5.2%)</td></tr>
    <tr><th id="stub_1_17" scope="row" class="gt_row gt_left gt_stub">COUGH</th>
<td headers="stub_1_17 Total" class="gt_row gt_left">11 (100.0%)</td>
<td headers="stub_1_17 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_17 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_17 Xanomeline High Dose" class="gt_row gt_left">5 (6.9%)</td>
<td headers="stub_1_17 Xanomeline Low Dose" class="gt_row gt_left">5 (5.2%)</td></tr>
    <tr><th id="stub_1_18" scope="row" class="gt_row gt_left gt_stub">FATIGUE</th>
<td headers="stub_1_18 Total" class="gt_row gt_left">11 (100.0%)</td>
<td headers="stub_1_18 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_18 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_18 Xanomeline High Dose" class="gt_row gt_left">5 (6.9%)</td>
<td headers="stub_1_18 Xanomeline Low Dose" class="gt_row gt_left">5 (5.2%)</td></tr>
    <tr><th id="stub_1_19" scope="row" class="gt_row gt_left gt_stub">HEADACHE</th>
<td headers="stub_1_19 Total" class="gt_row gt_left">11 (100.0%)</td>
<td headers="stub_1_19 Placebo" class="gt_row gt_left">3 (3.5%)</td>
<td headers="stub_1_19 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_19 Xanomeline High Dose" class="gt_row gt_left">5 (6.9%)</td>
<td headers="stub_1_19 Xanomeline Low Dose" class="gt_row gt_left">3 (3.1%)</td></tr>
    <tr><th id="stub_1_20" scope="row" class="gt_row gt_left gt_stub">MYOCARDIAL INFARCTION</th>
<td headers="stub_1_20 Total" class="gt_row gt_left">10 (100.0%)</td>
<td headers="stub_1_20 Placebo" class="gt_row gt_left">4 (4.7%)</td>
<td headers="stub_1_20 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_20 Xanomeline High Dose" class="gt_row gt_left">4 (5.6%)</td>
<td headers="stub_1_20 Xanomeline Low Dose" class="gt_row gt_left">2 (2.1%)</td></tr>
    <tr><th id="stub_1_21" scope="row" class="gt_row gt_left gt_stub">UPPER RESPIRATORY TRACT INFECTION</th>
<td headers="stub_1_21 Total" class="gt_row gt_left">10 (100.0%)</td>
<td headers="stub_1_21 Placebo" class="gt_row gt_left">6 (7.0%)</td>
<td headers="stub_1_21 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_21 Xanomeline High Dose" class="gt_row gt_left">3 (4.2%)</td>
<td headers="stub_1_21 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_22" scope="row" class="gt_row gt_left gt_stub">NASAL CONGESTION</th>
<td headers="stub_1_22 Total" class="gt_row gt_left">7 (100.0%)</td>
<td headers="stub_1_22 Placebo" class="gt_row gt_left">3 (3.5%)</td>
<td headers="stub_1_22 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_22 Xanomeline High Dose" class="gt_row gt_left">3 (4.2%)</td>
<td headers="stub_1_22 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_23" scope="row" class="gt_row gt_left gt_stub">SYNCOPE</th>
<td headers="stub_1_23 Total" class="gt_row gt_left">7 (100.0%)</td>
<td headers="stub_1_23 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_23 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_23 Xanomeline High Dose" class="gt_row gt_left">2 (2.8%)</td>
<td headers="stub_1_23 Xanomeline Low Dose" class="gt_row gt_left">5 (5.2%)</td></tr>
    <tr><th id="stub_1_24" scope="row" class="gt_row gt_left gt_stub">BLISTER</th>
<td headers="stub_1_24 Total" class="gt_row gt_left">6 (100.0%)</td>
<td headers="stub_1_24 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_24 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_24 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_24 Xanomeline Low Dose" class="gt_row gt_left">5 (5.2%)</td></tr>
    <tr><th id="stub_1_25" scope="row" class="gt_row gt_left gt_stub">CONFUSIONAL STATE</th>
<td headers="stub_1_25 Total" class="gt_row gt_left">6 (100.0%)</td>
<td headers="stub_1_25 Placebo" class="gt_row gt_left">2 (2.3%)</td>
<td headers="stub_1_25 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_25 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_25 Xanomeline Low Dose" class="gt_row gt_left">3 (3.1%)</td></tr>
    <tr><th id="stub_1_26" scope="row" class="gt_row gt_left gt_stub">SOMNOLENCE</th>
<td headers="stub_1_26 Total" class="gt_row gt_left">6 (100.0%)</td>
<td headers="stub_1_26 Placebo" class="gt_row gt_left">2 (2.3%)</td>
<td headers="stub_1_26 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_26 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_26 Xanomeline Low Dose" class="gt_row gt_left">3 (3.1%)</td></tr>
    <tr><th id="stub_1_27" scope="row" class="gt_row gt_left gt_stub">ABDOMINAL PAIN</th>
<td headers="stub_1_27 Total" class="gt_row gt_left">5 (100.0%)</td>
<td headers="stub_1_27 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_27 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_27 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_27 Xanomeline Low Dose" class="gt_row gt_left">3 (3.1%)</td></tr>
    <tr><th id="stub_1_28" scope="row" class="gt_row gt_left gt_stub">AGITATION</th>
<td headers="stub_1_28 Total" class="gt_row gt_left">5 (100.0%)</td>
<td headers="stub_1_28 Placebo" class="gt_row gt_left">2 (2.3%)</td>
<td headers="stub_1_28 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_28 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_28 Xanomeline Low Dose" class="gt_row gt_left">3 (3.1%)</td></tr>
    <tr><th id="stub_1_29" scope="row" class="gt_row gt_left gt_stub">ATRIAL FIBRILLATION</th>
<td headers="stub_1_29 Total" class="gt_row gt_left">5 (100.0%)</td>
<td headers="stub_1_29 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_29 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_29 Xanomeline High Dose" class="gt_row gt_left">2 (2.8%)</td>
<td headers="stub_1_29 Xanomeline Low Dose" class="gt_row gt_left">2 (2.1%)</td></tr>
    <tr><th id="stub_1_30" scope="row" class="gt_row gt_left gt_stub">BACK PAIN</th>
<td headers="stub_1_30 Total" class="gt_row gt_left">5 (100.0%)</td>
<td headers="stub_1_30 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_30 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_30 Xanomeline High Dose" class="gt_row gt_left">3 (4.2%)</td>
<td headers="stub_1_30 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_31" scope="row" class="gt_row gt_left gt_stub">ELECTROCARDIOGRAM ST SEGMENT DEPRESSION</th>
<td headers="stub_1_31 Total" class="gt_row gt_left">5 (100.0%)</td>
<td headers="stub_1_31 Placebo" class="gt_row gt_left">4 (4.7%)</td>
<td headers="stub_1_31 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_31 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_31 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_32" scope="row" class="gt_row gt_left gt_stub">OEDEMA PERIPHERAL</th>
<td headers="stub_1_32 Total" class="gt_row gt_left">5 (100.0%)</td>
<td headers="stub_1_32 Placebo" class="gt_row gt_left">2 (2.3%)</td>
<td headers="stub_1_32 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_32 Xanomeline High Dose" class="gt_row gt_left">2 (2.8%)</td>
<td headers="stub_1_32 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_33" scope="row" class="gt_row gt_left gt_stub">ARTHRALGIA</th>
<td headers="stub_1_33 Total" class="gt_row gt_left">4 (100.0%)</td>
<td headers="stub_1_33 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_33 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_33 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_33 Xanomeline Low Dose" class="gt_row gt_left">2 (2.1%)</td></tr>
    <tr><th id="stub_1_34" scope="row" class="gt_row gt_left gt_stub">CONTUSION</th>
<td headers="stub_1_34 Total" class="gt_row gt_left">4 (100.0%)</td>
<td headers="stub_1_34 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_34 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_34 Xanomeline High Dose" class="gt_row gt_left">2 (2.8%)</td>
<td headers="stub_1_34 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_35" scope="row" class="gt_row gt_left gt_stub">ELECTROCARDIOGRAM T WAVE INVERSION</th>
<td headers="stub_1_35 Total" class="gt_row gt_left">4 (100.0%)</td>
<td headers="stub_1_35 Placebo" class="gt_row gt_left">2 (2.3%)</td>
<td headers="stub_1_35 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_35 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_35 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_36" scope="row" class="gt_row gt_left gt_stub">EXCORIATION</th>
<td headers="stub_1_36 Total" class="gt_row gt_left">4 (100.0%)</td>
<td headers="stub_1_36 Placebo" class="gt_row gt_left">2 (2.3%)</td>
<td headers="stub_1_36 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_36 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_36 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_37" scope="row" class="gt_row gt_left gt_stub">FALL</th>
<td headers="stub_1_37 Total" class="gt_row gt_left">4 (100.0%)</td>
<td headers="stub_1_37 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_37 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_37 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_37 Xanomeline Low Dose" class="gt_row gt_left">2 (2.1%)</td></tr>
    <tr><th id="stub_1_38" scope="row" class="gt_row gt_left gt_stub">INSOMNIA</th>
<td headers="stub_1_38 Total" class="gt_row gt_left">4 (100.0%)</td>
<td headers="stub_1_38 Placebo" class="gt_row gt_left">2 (2.3%)</td>
<td headers="stub_1_38 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_38 Xanomeline High Dose" class="gt_row gt_left">2 (2.8%)</td>
<td headers="stub_1_38 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_39" scope="row" class="gt_row gt_left gt_stub">SALIVARY HYPERSECRETION</th>
<td headers="stub_1_39 Total" class="gt_row gt_left">4 (100.0%)</td>
<td headers="stub_1_39 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_39 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_39 Xanomeline High Dose" class="gt_row gt_left">4 (5.6%)</td>
<td headers="stub_1_39 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_40" scope="row" class="gt_row gt_left gt_stub">ANXIETY</th>
<td headers="stub_1_40 Total" class="gt_row gt_left">3 (100.0%)</td>
<td headers="stub_1_40 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_40 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_40 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_40 Xanomeline Low Dose" class="gt_row gt_left">3 (3.1%)</td></tr>
    <tr><th id="stub_1_41" scope="row" class="gt_row gt_left gt_stub">APPLICATION SITE SWELLING</th>
<td headers="stub_1_41 Total" class="gt_row gt_left">3 (100.0%)</td>
<td headers="stub_1_41 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_41 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_41 Xanomeline High Dose" class="gt_row gt_left">2 (2.8%)</td>
<td headers="stub_1_41 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_42" scope="row" class="gt_row gt_left gt_stub">APPLICATION SITE URTICARIA</th>
<td headers="stub_1_42 Total" class="gt_row gt_left">3 (100.0%)</td>
<td headers="stub_1_42 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_42 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_42 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_42 Xanomeline Low Dose" class="gt_row gt_left">2 (2.1%)</td></tr>
    <tr><th id="stub_1_43" scope="row" class="gt_row gt_left gt_stub">CHILLS</th>
<td headers="stub_1_43 Total" class="gt_row gt_left">3 (100.0%)</td>
<td headers="stub_1_43 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_43 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_43 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_43 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_44" scope="row" class="gt_row gt_left gt_stub">DYSPNOEA</th>
<td headers="stub_1_44 Total" class="gt_row gt_left">3 (100.0%)</td>
<td headers="stub_1_44 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_44 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_44 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_44 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_45" scope="row" class="gt_row gt_left gt_stub">EPISTAXIS</th>
<td headers="stub_1_45 Total" class="gt_row gt_left">3 (100.0%)</td>
<td headers="stub_1_45 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_45 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_45 Xanomeline High Dose" class="gt_row gt_left">2 (2.8%)</td>
<td headers="stub_1_45 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_46" scope="row" class="gt_row gt_left gt_stub">HIP FRACTURE</th>
<td headers="stub_1_46 Total" class="gt_row gt_left">3 (100.0%)</td>
<td headers="stub_1_46 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_46 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_46 Xanomeline High Dose" class="gt_row gt_left">2 (2.8%)</td>
<td headers="stub_1_46 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_47" scope="row" class="gt_row gt_left gt_stub">HYPOTENSION</th>
<td headers="stub_1_47 Total" class="gt_row gt_left">3 (100.0%)</td>
<td headers="stub_1_47 Placebo" class="gt_row gt_left">2 (2.3%)</td>
<td headers="stub_1_47 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_47 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_47 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_48" scope="row" class="gt_row gt_left gt_stub">INFLUENZA</th>
<td headers="stub_1_48 Total" class="gt_row gt_left">3 (100.0%)</td>
<td headers="stub_1_48 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_48 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_48 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_48 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_49" scope="row" class="gt_row gt_left gt_stub">MALAISE</th>
<td headers="stub_1_49 Total" class="gt_row gt_left">3 (100.0%)</td>
<td headers="stub_1_49 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_49 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_49 Xanomeline High Dose" class="gt_row gt_left">2 (2.8%)</td>
<td headers="stub_1_49 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_50" scope="row" class="gt_row gt_left gt_stub">MICTURITION URGENCY</th>
<td headers="stub_1_50 Total" class="gt_row gt_left">3 (100.0%)</td>
<td headers="stub_1_50 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_50 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_50 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_50 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_51" scope="row" class="gt_row gt_left gt_stub">PYREXIA</th>
<td headers="stub_1_51 Total" class="gt_row gt_left">3 (100.0%)</td>
<td headers="stub_1_51 Placebo" class="gt_row gt_left">2 (2.3%)</td>
<td headers="stub_1_51 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_51 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_51 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_52" scope="row" class="gt_row gt_left gt_stub">RASH PRURITIC</th>
<td headers="stub_1_52 Total" class="gt_row gt_left">3 (100.0%)</td>
<td headers="stub_1_52 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_52 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_52 Xanomeline High Dose" class="gt_row gt_left">2 (2.8%)</td>
<td headers="stub_1_52 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_53" scope="row" class="gt_row gt_left gt_stub">SHOULDER PAIN</th>
<td headers="stub_1_53 Total" class="gt_row gt_left">3 (100.0%)</td>
<td headers="stub_1_53 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_53 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_53 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_53 Xanomeline Low Dose" class="gt_row gt_left">2 (2.1%)</td></tr>
    <tr><th id="stub_1_54" scope="row" class="gt_row gt_left gt_stub">SKIN LACERATION</th>
<td headers="stub_1_54 Total" class="gt_row gt_left">3 (100.0%)</td>
<td headers="stub_1_54 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_54 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_54 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_54 Xanomeline Low Dose" class="gt_row gt_left">2 (2.1%)</td></tr>
    <tr><th id="stub_1_55" scope="row" class="gt_row gt_left gt_stub">SUPRAVENTRICULAR EXTRASYSTOLES</th>
<td headers="stub_1_55 Total" class="gt_row gt_left">3 (100.0%)</td>
<td headers="stub_1_55 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_55 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_55 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_55 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_56" scope="row" class="gt_row gt_left gt_stub">TRANSIENT ISCHAEMIC ATTACK</th>
<td headers="stub_1_56 Total" class="gt_row gt_left">3 (100.0%)</td>
<td headers="stub_1_56 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_56 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_56 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_56 Xanomeline Low Dose" class="gt_row gt_left">2 (2.1%)</td></tr>
    <tr><th id="stub_1_57" scope="row" class="gt_row gt_left gt_stub">URINARY TRACT INFECTION</th>
<td headers="stub_1_57 Total" class="gt_row gt_left">3 (100.0%)</td>
<td headers="stub_1_57 Placebo" class="gt_row gt_left">2 (2.3%)</td>
<td headers="stub_1_57 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_57 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_57 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_58" scope="row" class="gt_row gt_left gt_stub">VENTRICULAR EXTRASYSTOLES</th>
<td headers="stub_1_58 Total" class="gt_row gt_left">3 (100.0%)</td>
<td headers="stub_1_58 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_58 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_58 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_58 Xanomeline Low Dose" class="gt_row gt_left">2 (2.1%)</td></tr>
    <tr><th id="stub_1_59" scope="row" class="gt_row gt_left gt_stub">VENTRICULAR SEPTAL DEFECT</th>
<td headers="stub_1_59 Total" class="gt_row gt_left">3 (100.0%)</td>
<td headers="stub_1_59 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_59 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_59 Xanomeline High Dose" class="gt_row gt_left">2 (2.8%)</td>
<td headers="stub_1_59 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_60" scope="row" class="gt_row gt_left gt_stub">APPLICATION SITE PAIN</th>
<td headers="stub_1_60 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_60 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_60 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_60 Xanomeline High Dose" class="gt_row gt_left">2 (2.8%)</td>
<td headers="stub_1_60 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_61" scope="row" class="gt_row gt_left gt_stub">APPLICATION SITE PERSPIRATION</th>
<td headers="stub_1_61 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_61 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_61 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_61 Xanomeline High Dose" class="gt_row gt_left">2 (2.8%)</td>
<td headers="stub_1_61 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_62" scope="row" class="gt_row gt_left gt_stub">APPLICATION SITE REACTION</th>
<td headers="stub_1_62 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_62 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_62 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_62 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_62 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_63" scope="row" class="gt_row gt_left gt_stub">ASTHENIA</th>
<td headers="stub_1_63 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_63 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_63 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_63 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_63 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_64" scope="row" class="gt_row gt_left gt_stub">ATRIAL FLUTTER</th>
<td headers="stub_1_64 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_64 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_64 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_64 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_64 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_65" scope="row" class="gt_row gt_left gt_stub">ATRIOVENTRICULAR BLOCK FIRST DEGREE</th>
<td headers="stub_1_65 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_65 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_65 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_65 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_65 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_66" scope="row" class="gt_row gt_left gt_stub">BENIGN PROSTATIC HYPERPLASIA</th>
<td headers="stub_1_66 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_66 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_66 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_66 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_66 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_67" scope="row" class="gt_row gt_left gt_stub">BLOOD GLUCOSE INCREASED</th>
<td headers="stub_1_67 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_67 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_67 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_67 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_67 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_68" scope="row" class="gt_row gt_left gt_stub">BUNDLE BRANCH BLOCK RIGHT</th>
<td headers="stub_1_68 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_68 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_68 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_68 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_68 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_69" scope="row" class="gt_row gt_left gt_stub">BURNING SENSATION</th>
<td headers="stub_1_69 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_69 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_69 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_69 Xanomeline High Dose" class="gt_row gt_left">2 (2.8%)</td>
<td headers="stub_1_69 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_70" scope="row" class="gt_row gt_left gt_stub">CATARACT OPERATION</th>
<td headers="stub_1_70 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_70 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_70 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_70 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_70 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_71" scope="row" class="gt_row gt_left gt_stub">CHEST DISCOMFORT</th>
<td headers="stub_1_71 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_71 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_71 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_71 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_71 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_72" scope="row" class="gt_row gt_left gt_stub">CHEST PAIN</th>
<td headers="stub_1_72 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_72 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_72 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_72 Xanomeline High Dose" class="gt_row gt_left">2 (2.8%)</td>
<td headers="stub_1_72 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_73" scope="row" class="gt_row gt_left gt_stub">CYSTITIS</th>
<td headers="stub_1_73 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_73 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_73 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_73 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_73 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_74" scope="row" class="gt_row gt_left gt_stub">DECREASED APPETITE</th>
<td headers="stub_1_74 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_74 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_74 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_74 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_74 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_75" scope="row" class="gt_row gt_left gt_stub">DELUSION</th>
<td headers="stub_1_75 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_75 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_75 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_75 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_75 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_76" scope="row" class="gt_row gt_left gt_stub">DYSPEPSIA</th>
<td headers="stub_1_76 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_76 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_76 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_76 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_76 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_77" scope="row" class="gt_row gt_left gt_stub">DYSURIA</th>
<td headers="stub_1_77 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_77 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_77 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_77 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_77 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_78" scope="row" class="gt_row gt_left gt_stub">EAR INFECTION</th>
<td headers="stub_1_78 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_78 Placebo" class="gt_row gt_left">2 (2.3%)</td>
<td headers="stub_1_78 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_78 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_78 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_79" scope="row" class="gt_row gt_left gt_stub">ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED</th>
<td headers="stub_1_79 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_79 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_79 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_79 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_79 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_80" scope="row" class="gt_row gt_left gt_stub">FOOD CRAVING</th>
<td headers="stub_1_80 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_80 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_80 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_80 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_80 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_81" scope="row" class="gt_row gt_left gt_stub">HYPERTENSION</th>
<td headers="stub_1_81 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_81 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_81 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_81 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_81 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_82" scope="row" class="gt_row gt_left gt_stub">INCREASED APPETITE</th>
<td headers="stub_1_82 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_82 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_82 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_82 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_82 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_83" scope="row" class="gt_row gt_left gt_stub">IRRITABILITY</th>
<td headers="stub_1_83 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_83 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_83 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_83 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_83 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_84" scope="row" class="gt_row gt_left gt_stub">LETHARGY</th>
<td headers="stub_1_84 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_84 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_84 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_84 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_84 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_85" scope="row" class="gt_row gt_left gt_stub">MUSCLE SPASMS</th>
<td headers="stub_1_85 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_85 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_85 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_85 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_85 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_86" scope="row" class="gt_row gt_left gt_stub">NEPHROLITHIASIS</th>
<td headers="stub_1_86 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_86 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_86 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_86 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_86 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_87" scope="row" class="gt_row gt_left gt_stub">OEDEMA</th>
<td headers="stub_1_87 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_87 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_87 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_87 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_87 Xanomeline Low Dose" class="gt_row gt_left">2 (2.1%)</td></tr>
    <tr><th id="stub_1_88" scope="row" class="gt_row gt_left gt_stub">PAIN</th>
<td headers="stub_1_88 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_88 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_88 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_88 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_88 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_89" scope="row" class="gt_row gt_left gt_stub">PALPITATIONS</th>
<td headers="stub_1_89 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_89 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_89 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_89 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_89 Xanomeline Low Dose" class="gt_row gt_left">2 (2.1%)</td></tr>
    <tr><th id="stub_1_90" scope="row" class="gt_row gt_left gt_stub">PHARYNGOLARYNGEAL PAIN</th>
<td headers="stub_1_90 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_90 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_90 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_90 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_90 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_91" scope="row" class="gt_row gt_left gt_stub">PRURITUS GENERALISED</th>
<td headers="stub_1_91 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_91 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_91 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_91 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_91 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_92" scope="row" class="gt_row gt_left gt_stub">RHINORRHOEA</th>
<td headers="stub_1_92 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_92 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_92 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_92 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_92 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_93" scope="row" class="gt_row gt_left gt_stub">URTICARIA</th>
<td headers="stub_1_93 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_93 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_93 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_93 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_93 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_94" scope="row" class="gt_row gt_left gt_stub">VERTIGO</th>
<td headers="stub_1_94 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_94 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_94 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_94 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_94 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_95" scope="row" class="gt_row gt_left gt_stub">VISION BLURRED</th>
<td headers="stub_1_95 Total" class="gt_row gt_left">2 (100.0%)</td>
<td headers="stub_1_95 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_95 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_95 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_95 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_96" scope="row" class="gt_row gt_left gt_stub">ABDOMINAL DISCOMFORT</th>
<td headers="stub_1_96 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_96 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_96 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_96 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_96 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_97" scope="row" class="gt_row gt_left gt_stub">ACROCHORDON EXCISION</th>
<td headers="stub_1_97 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_97 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_97 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_97 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_97 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_98" scope="row" class="gt_row gt_left gt_stub">ACTINIC KERATOSIS</th>
<td headers="stub_1_98 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_98 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_98 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_98 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_98 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_99" scope="row" class="gt_row gt_left gt_stub">ALCOHOL USE</th>
<td headers="stub_1_99 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_99 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_99 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_99 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_99 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_100" scope="row" class="gt_row gt_left gt_stub">ALLERGIC GRANULOMATOUS ANGIITIS</th>
<td headers="stub_1_100 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_100 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_100 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_100 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_100 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_101" scope="row" class="gt_row gt_left gt_stub">ALOPECIA</th>
<td headers="stub_1_101 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_101 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_101 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_101 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_101 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_102" scope="row" class="gt_row gt_left gt_stub">AMNESIA</th>
<td headers="stub_1_102 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_102 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_102 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_102 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_102 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_103" scope="row" class="gt_row gt_left gt_stub">APPLICATION SITE BLEEDING</th>
<td headers="stub_1_103 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_103 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_103 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_103 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_103 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_104" scope="row" class="gt_row gt_left gt_stub">APPLICATION SITE DESQUAMATION</th>
<td headers="stub_1_104 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_104 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_104 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_104 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_104 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_105" scope="row" class="gt_row gt_left gt_stub">APPLICATION SITE DISCHARGE</th>
<td headers="stub_1_105 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_105 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_105 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_105 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_105 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_106" scope="row" class="gt_row gt_left gt_stub">APPLICATION SITE DISCOLOURATION</th>
<td headers="stub_1_106 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_106 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_106 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_106 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_106 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_107" scope="row" class="gt_row gt_left gt_stub">APPLICATION SITE INDURATION</th>
<td headers="stub_1_107 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_107 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_107 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_107 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_107 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_108" scope="row" class="gt_row gt_left gt_stub">APPLICATION SITE WARMTH</th>
<td headers="stub_1_108 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_108 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_108 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_108 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_108 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_109" scope="row" class="gt_row gt_left gt_stub">ARTHRITIS</th>
<td headers="stub_1_109 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_109 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_109 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_109 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_109 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_110" scope="row" class="gt_row gt_left gt_stub">ATRIAL HYPERTROPHY</th>
<td headers="stub_1_110 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_110 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_110 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_110 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_110 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_111" scope="row" class="gt_row gt_left gt_stub">ATRIOVENTRICULAR BLOCK SECOND DEGREE</th>
<td headers="stub_1_111 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_111 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_111 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_111 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_111 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_112" scope="row" class="gt_row gt_left gt_stub">BALANCE DISORDER</th>
<td headers="stub_1_112 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_112 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_112 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_112 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_112 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_113" scope="row" class="gt_row gt_left gt_stub">BIOPSY</th>
<td headers="stub_1_113 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_113 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_113 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_113 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_113 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_114" scope="row" class="gt_row gt_left gt_stub">BIOPSY PROSTATE</th>
<td headers="stub_1_114 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_114 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_114 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_114 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_114 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_115" scope="row" class="gt_row gt_left gt_stub">BLOOD ALKALINE PHOSPHATASE INCREASED</th>
<td headers="stub_1_115 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_115 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_115 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_115 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_115 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_116" scope="row" class="gt_row gt_left gt_stub">BLOOD CHOLESTEROL INCREASED</th>
<td headers="stub_1_116 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_116 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_116 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_116 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_116 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_117" scope="row" class="gt_row gt_left gt_stub">BLOOD CREATINE PHOSPHOKINASE INCREASED</th>
<td headers="stub_1_117 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_117 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_117 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_117 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_117 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_118" scope="row" class="gt_row gt_left gt_stub">BLOOD URINE PRESENT</th>
<td headers="stub_1_118 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_118 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_118 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_118 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_118 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_119" scope="row" class="gt_row gt_left gt_stub">BODY TEMPERATURE INCREASED</th>
<td headers="stub_1_119 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_119 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_119 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_119 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_119 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_120" scope="row" class="gt_row gt_left gt_stub">BRADYCARDIA</th>
<td headers="stub_1_120 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_120 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_120 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_120 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_120 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_121" scope="row" class="gt_row gt_left gt_stub">BRONCHITIS</th>
<td headers="stub_1_121 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_121 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_121 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_121 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_121 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_122" scope="row" class="gt_row gt_left gt_stub">BUNDLE BRANCH BLOCK LEFT</th>
<td headers="stub_1_122 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_122 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_122 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_122 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_122 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_123" scope="row" class="gt_row gt_left gt_stub">CALCULUS URETHRAL</th>
<td headers="stub_1_123 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_123 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_123 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_123 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_123 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_124" scope="row" class="gt_row gt_left gt_stub">CARDIAC DISORDER</th>
<td headers="stub_1_124 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_124 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_124 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_124 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_124 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_125" scope="row" class="gt_row gt_left gt_stub">CARDIAC FAILURE CONGESTIVE</th>
<td headers="stub_1_125 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_125 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_125 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_125 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_125 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_126" scope="row" class="gt_row gt_left gt_stub">CELLULITIS</th>
<td headers="stub_1_126 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_126 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_126 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_126 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_126 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_127" scope="row" class="gt_row gt_left gt_stub">CERUMEN IMPACTION</th>
<td headers="stub_1_127 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_127 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_127 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_127 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_127 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_128" scope="row" class="gt_row gt_left gt_stub">CERVICITIS</th>
<td headers="stub_1_128 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_128 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_128 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_128 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_128 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_129" scope="row" class="gt_row gt_left gt_stub">COGNITIVE DISORDER</th>
<td headers="stub_1_129 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_129 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_129 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_129 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_129 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_130" scope="row" class="gt_row gt_left gt_stub">COLD SWEAT</th>
<td headers="stub_1_130 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_130 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_130 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_130 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_130 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_131" scope="row" class="gt_row gt_left gt_stub">COLON CANCER</th>
<td headers="stub_1_131 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_131 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_131 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_131 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_131 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_132" scope="row" class="gt_row gt_left gt_stub">COMPLETED SUICIDE</th>
<td headers="stub_1_132 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_132 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_132 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_132 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_132 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_133" scope="row" class="gt_row gt_left gt_stub">COMPLEX PARTIAL SEIZURES</th>
<td headers="stub_1_133 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_133 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_133 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_133 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_133 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_134" scope="row" class="gt_row gt_left gt_stub">CONJUNCTIVAL HAEMORRHAGE</th>
<td headers="stub_1_134 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_134 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_134 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_134 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_134 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_135" scope="row" class="gt_row gt_left gt_stub">CONJUNCTIVITIS</th>
<td headers="stub_1_135 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_135 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_135 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_135 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_135 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_136" scope="row" class="gt_row gt_left gt_stub">CONSTIPATION</th>
<td headers="stub_1_136 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_136 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_136 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_136 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_136 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_137" scope="row" class="gt_row gt_left gt_stub">COORDINATION ABNORMAL</th>
<td headers="stub_1_137 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_137 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_137 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_137 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_137 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_138" scope="row" class="gt_row gt_left gt_stub">CYSTOSCOPY</th>
<td headers="stub_1_138 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_138 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_138 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_138 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_138 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_139" scope="row" class="gt_row gt_left gt_stub">DEHYDRATION</th>
<td headers="stub_1_139 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_139 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_139 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_139 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_139 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_140" scope="row" class="gt_row gt_left gt_stub">DELIRIUM</th>
<td headers="stub_1_140 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_140 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_140 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_140 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_140 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_141" scope="row" class="gt_row gt_left gt_stub">DEPRESSED MOOD</th>
<td headers="stub_1_141 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_141 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_141 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_141 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_141 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_142" scope="row" class="gt_row gt_left gt_stub">DERMATITIS CONTACT</th>
<td headers="stub_1_142 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_142 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_142 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_142 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_142 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_143" scope="row" class="gt_row gt_left gt_stub">DIABETES MELLITUS</th>
<td headers="stub_1_143 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_143 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_143 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_143 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_143 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_144" scope="row" class="gt_row gt_left gt_stub">DISORIENTATION</th>
<td headers="stub_1_144 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_144 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_144 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_144 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_144 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_145" scope="row" class="gt_row gt_left gt_stub">DRUG ERUPTION</th>
<td headers="stub_1_145 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_145 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_145 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_145 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_145 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_146" scope="row" class="gt_row gt_left gt_stub">DYSPHAGIA</th>
<td headers="stub_1_146 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_146 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_146 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_146 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_146 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_147" scope="row" class="gt_row gt_left gt_stub">DYSPHONIA</th>
<td headers="stub_1_147 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_147 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_147 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_147 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_147 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_148" scope="row" class="gt_row gt_left gt_stub">EAR PAIN</th>
<td headers="stub_1_148 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_148 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_148 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_148 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_148 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_149" scope="row" class="gt_row gt_left gt_stub">EMPHYSEMA</th>
<td headers="stub_1_149 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_149 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_149 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_149 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_149 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_150" scope="row" class="gt_row gt_left gt_stub">EYE ALLERGY</th>
<td headers="stub_1_150 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_150 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_150 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_150 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_150 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_151" scope="row" class="gt_row gt_left gt_stub">EYE LASER SURGERY</th>
<td headers="stub_1_151 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_151 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_151 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_151 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_151 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_152" scope="row" class="gt_row gt_left gt_stub">EYE PRURITUS</th>
<td headers="stub_1_152 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_152 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_152 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_152 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_152 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_153" scope="row" class="gt_row gt_left gt_stub">EYE SWELLING</th>
<td headers="stub_1_153 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_153 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_153 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_153 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_153 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_154" scope="row" class="gt_row gt_left gt_stub">FACIAL BONES FRACTURE</th>
<td headers="stub_1_154 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_154 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_154 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_154 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_154 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_155" scope="row" class="gt_row gt_left gt_stub">FEELING ABNORMAL</th>
<td headers="stub_1_155 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_155 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_155 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_155 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_155 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_156" scope="row" class="gt_row gt_left gt_stub">FEELING COLD</th>
<td headers="stub_1_156 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_156 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_156 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_156 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_156 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_157" scope="row" class="gt_row gt_left gt_stub">FLANK PAIN</th>
<td headers="stub_1_157 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_157 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_157 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_157 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_157 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_158" scope="row" class="gt_row gt_left gt_stub">FLATULENCE</th>
<td headers="stub_1_158 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_158 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_158 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_158 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_158 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_159" scope="row" class="gt_row gt_left gt_stub">GASTROENTERITIS VIRAL</th>
<td headers="stub_1_159 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_159 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_159 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_159 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_159 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_160" scope="row" class="gt_row gt_left gt_stub">GASTROINTESTINAL HAEMORRHAGE</th>
<td headers="stub_1_160 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_160 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_160 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_160 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_160 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_161" scope="row" class="gt_row gt_left gt_stub">GASTROOESOPHAGEAL REFLUX DISEASE</th>
<td headers="stub_1_161 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_161 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_161 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_161 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_161 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_162" scope="row" class="gt_row gt_left gt_stub">GLOSSITIS</th>
<td headers="stub_1_162 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_162 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_162 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_162 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_162 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_163" scope="row" class="gt_row gt_left gt_stub">HAEMOPTYSIS</th>
<td headers="stub_1_163 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_163 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_163 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_163 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_163 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_164" scope="row" class="gt_row gt_left gt_stub">HALLUCINATION</th>
<td headers="stub_1_164 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_164 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_164 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_164 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_164 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_165" scope="row" class="gt_row gt_left gt_stub">HALLUCINATION, VISUAL</th>
<td headers="stub_1_165 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_165 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_165 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_165 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_165 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_166" scope="row" class="gt_row gt_left gt_stub">HEART RATE INCREASED</th>
<td headers="stub_1_166 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_166 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_166 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_166 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_166 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_167" scope="row" class="gt_row gt_left gt_stub">HEART RATE IRREGULAR</th>
<td headers="stub_1_167 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_167 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_167 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_167 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_167 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_168" scope="row" class="gt_row gt_left gt_stub">HEMIANOPIA HOMONYMOUS</th>
<td headers="stub_1_168 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_168 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_168 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_168 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_168 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_169" scope="row" class="gt_row gt_left gt_stub">HIATUS HERNIA</th>
<td headers="stub_1_169 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_169 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_169 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_169 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_169 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_170" scope="row" class="gt_row gt_left gt_stub">HORDEOLUM</th>
<td headers="stub_1_170 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_170 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_170 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_170 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_170 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_171" scope="row" class="gt_row gt_left gt_stub">HOT FLUSH</th>
<td headers="stub_1_171 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_171 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_171 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_171 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_171 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_172" scope="row" class="gt_row gt_left gt_stub">HYPERBILIRUBINAEMIA</th>
<td headers="stub_1_172 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_172 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_172 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_172 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_172 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_173" scope="row" class="gt_row gt_left gt_stub">HYPERSENSITIVITY</th>
<td headers="stub_1_173 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_173 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_173 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_173 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_173 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_174" scope="row" class="gt_row gt_left gt_stub">HYPERSOMNIA</th>
<td headers="stub_1_174 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_174 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_174 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_174 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_174 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_175" scope="row" class="gt_row gt_left gt_stub">HYPONATRAEMIA</th>
<td headers="stub_1_175 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_175 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_175 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_175 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_175 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_176" scope="row" class="gt_row gt_left gt_stub">INCONTINENCE</th>
<td headers="stub_1_176 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_176 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_176 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_176 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_176 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_177" scope="row" class="gt_row gt_left gt_stub">INFLAMMATION</th>
<td headers="stub_1_177 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_177 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_177 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_177 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_177 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_178" scope="row" class="gt_row gt_left gt_stub">JOINT DISLOCATION</th>
<td headers="stub_1_178 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_178 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_178 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_178 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_178 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_179" scope="row" class="gt_row gt_left gt_stub">LIBIDO DECREASED</th>
<td headers="stub_1_179 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_179 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_179 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_179 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_179 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_180" scope="row" class="gt_row gt_left gt_stub">LISTLESS</th>
<td headers="stub_1_180 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_180 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_180 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_180 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_180 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_181" scope="row" class="gt_row gt_left gt_stub">LOCALISED INFECTION</th>
<td headers="stub_1_181 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_181 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_181 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_181 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_181 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_182" scope="row" class="gt_row gt_left gt_stub">LOWER RESPIRATORY TRACT INFECTION</th>
<td headers="stub_1_182 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_182 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_182 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_182 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_182 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_183" scope="row" class="gt_row gt_left gt_stub">MALIGNANT FIBROUS HISTIOCYTOMA</th>
<td headers="stub_1_183 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_183 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_183 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_183 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_183 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_184" scope="row" class="gt_row gt_left gt_stub">MUSCULAR WEAKNESS</th>
<td headers="stub_1_184 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_184 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_184 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_184 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_184 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_185" scope="row" class="gt_row gt_left gt_stub">MYALGIA</th>
<td headers="stub_1_185 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_185 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_185 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_185 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_185 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_186" scope="row" class="gt_row gt_left gt_stub">NASAL MUCOSA BIOPSY</th>
<td headers="stub_1_186 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_186 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_186 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_186 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_186 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_187" scope="row" class="gt_row gt_left gt_stub">NIGHTMARE</th>
<td headers="stub_1_187 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_187 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_187 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_187 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_187 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_188" scope="row" class="gt_row gt_left gt_stub">ORTHOSTATIC HYPOTENSION</th>
<td headers="stub_1_188 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_188 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_188 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_188 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_188 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_189" scope="row" class="gt_row gt_left gt_stub">PAIN IN EXTREMITY</th>
<td headers="stub_1_189 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_189 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_189 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_189 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_189 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_190" scope="row" class="gt_row gt_left gt_stub">PARAESTHESIA</th>
<td headers="stub_1_190 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_190 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_190 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_190 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_190 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_191" scope="row" class="gt_row gt_left gt_stub">PARAESTHESIA ORAL</th>
<td headers="stub_1_191 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_191 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_191 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_191 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_191 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_192" scope="row" class="gt_row gt_left gt_stub">PARKINSON'S DISEASE</th>
<td headers="stub_1_192 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_192 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_192 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_192 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_192 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_193" scope="row" class="gt_row gt_left gt_stub">PAROSMIA</th>
<td headers="stub_1_193 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_193 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_193 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_193 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_193 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_194" scope="row" class="gt_row gt_left gt_stub">PARTIAL SEIZURES WITH SECONDARY GENERALISATION</th>
<td headers="stub_1_194 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_194 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_194 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_194 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_194 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_195" scope="row" class="gt_row gt_left gt_stub">PELVIC PAIN</th>
<td headers="stub_1_195 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_195 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_195 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_195 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_195 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_196" scope="row" class="gt_row gt_left gt_stub">PHARYNGEAL ERYTHEMA</th>
<td headers="stub_1_196 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_196 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_196 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_196 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_196 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_197" scope="row" class="gt_row gt_left gt_stub">PNEUMONIA</th>
<td headers="stub_1_197 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_197 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_197 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_197 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_197 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_198" scope="row" class="gt_row gt_left gt_stub">POLLAKIURIA</th>
<td headers="stub_1_198 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_198 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_198 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_198 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_198 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_199" scope="row" class="gt_row gt_left gt_stub">POSTNASAL DRIP</th>
<td headers="stub_1_199 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_199 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_199 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_199 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_199 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_200" scope="row" class="gt_row gt_left gt_stub">PRODUCTIVE COUGH</th>
<td headers="stub_1_200 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_200 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_200 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_200 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_200 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_201" scope="row" class="gt_row gt_left gt_stub">PROSTATE CANCER</th>
<td headers="stub_1_201 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_201 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_201 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_201 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_201 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_202" scope="row" class="gt_row gt_left gt_stub">PSYCHOMOTOR HYPERACTIVITY</th>
<td headers="stub_1_202 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_202 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_202 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_202 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_202 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_203" scope="row" class="gt_row gt_left gt_stub">RALES</th>
<td headers="stub_1_203 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_203 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_203 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_203 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_203 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_204" scope="row" class="gt_row gt_left gt_stub">RASH ERYTHEMATOUS</th>
<td headers="stub_1_204 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_204 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_204 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_204 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_204 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_205" scope="row" class="gt_row gt_left gt_stub">RASH MACULO-PAPULAR</th>
<td headers="stub_1_205 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_205 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_205 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_205 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_205 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_206" scope="row" class="gt_row gt_left gt_stub">RECTAL HAEMORRHAGE</th>
<td headers="stub_1_206 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_206 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_206 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_206 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_206 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_207" scope="row" class="gt_row gt_left gt_stub">RESPIRATORY TRACT CONGESTION</th>
<td headers="stub_1_207 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_207 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_207 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_207 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_207 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_208" scope="row" class="gt_row gt_left gt_stub">RESTLESSNESS</th>
<td headers="stub_1_208 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_208 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_208 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_208 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_208 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_209" scope="row" class="gt_row gt_left gt_stub">RHINITIS</th>
<td headers="stub_1_209 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_209 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_209 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_209 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_209 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_210" scope="row" class="gt_row gt_left gt_stub">SECRETION DISCHARGE</th>
<td headers="stub_1_210 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_210 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_210 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_210 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_210 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_211" scope="row" class="gt_row gt_left gt_stub">SINUS ARRHYTHMIA</th>
<td headers="stub_1_211 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_211 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_211 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_211 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_211 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_212" scope="row" class="gt_row gt_left gt_stub">SKIN EXFOLIATION</th>
<td headers="stub_1_212 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_212 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_212 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_212 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_212 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_213" scope="row" class="gt_row gt_left gt_stub">SKIN LESION EXCISION</th>
<td headers="stub_1_213 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_213 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_213 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_213 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_213 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_214" scope="row" class="gt_row gt_left gt_stub">SKIN ODOUR ABNORMAL</th>
<td headers="stub_1_214 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_214 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_214 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_214 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_214 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_215" scope="row" class="gt_row gt_left gt_stub">SKIN ULCER</th>
<td headers="stub_1_215 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_215 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_215 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_215 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_215 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_216" scope="row" class="gt_row gt_left gt_stub">STOMACH DISCOMFORT</th>
<td headers="stub_1_216 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_216 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_216 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_216 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_216 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_217" scope="row" class="gt_row gt_left gt_stub">STUPOR</th>
<td headers="stub_1_217 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_217 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_217 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_217 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_217 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_218" scope="row" class="gt_row gt_left gt_stub">SUDDEN DEATH</th>
<td headers="stub_1_218 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_218 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_218 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_218 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_218 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_219" scope="row" class="gt_row gt_left gt_stub">SUPRAVENTRICULAR TACHYCARDIA</th>
<td headers="stub_1_219 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_219 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_219 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_219 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_219 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_220" scope="row" class="gt_row gt_left gt_stub">SWELLING</th>
<td headers="stub_1_220 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_220 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_220 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_220 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_220 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_221" scope="row" class="gt_row gt_left gt_stub">SYNCOPE VASOVAGAL</th>
<td headers="stub_1_221 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_221 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_221 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_221 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_221 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_222" scope="row" class="gt_row gt_left gt_stub">TACHYCARDIA</th>
<td headers="stub_1_222 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_222 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_222 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_222 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_222 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_223" scope="row" class="gt_row gt_left gt_stub">ULCER</th>
<td headers="stub_1_223 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_223 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_223 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_223 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_223 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_224" scope="row" class="gt_row gt_left gt_stub">VAGINAL MYCOSIS</th>
<td headers="stub_1_224 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_224 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_224 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_224 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_224 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_225" scope="row" class="gt_row gt_left gt_stub">VENTRICULAR HYPERTROPHY</th>
<td headers="stub_1_225 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_225 Placebo" class="gt_row gt_left">1 (1.2%)</td>
<td headers="stub_1_225 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_225 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_225 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
    <tr><th id="stub_1_226" scope="row" class="gt_row gt_left gt_stub">VIRAL INFECTION</th>
<td headers="stub_1_226 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_226 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_226 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_226 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_226 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_227" scope="row" class="gt_row gt_left gt_stub">WEIGHT DECREASED</th>
<td headers="stub_1_227 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_227 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_227 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_227 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_227 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_228" scope="row" class="gt_row gt_left gt_stub">WOLFF-PARKINSON-WHITE SYNDROME</th>
<td headers="stub_1_228 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_228 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_228 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_228 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_228 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_229" scope="row" class="gt_row gt_left gt_stub">WOUND</th>
<td headers="stub_1_229 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_229 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_229 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_229 Xanomeline High Dose" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_229 Xanomeline Low Dose" class="gt_row gt_left">1 (1.0%)</td></tr>
    <tr><th id="stub_1_230" scope="row" class="gt_row gt_left gt_stub">WOUND HAEMORRHAGE</th>
<td headers="stub_1_230 Total" class="gt_row gt_left">1 (100.0%)</td>
<td headers="stub_1_230 Placebo" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_230 Screen Failure" class="gt_row gt_left">0 (0.0%)</td>
<td headers="stub_1_230 Xanomeline High Dose" class="gt_row gt_left">1 (1.4%)</td>
<td headers="stub_1_230 Xanomeline Low Dose" class="gt_row gt_left">0 (0.0%)</td></tr>
  </tbody>
  
</table>
</div>
</body>
</html>
